Status:

COMPLETED

Innovative Gait Biofeedback Strategies for Stroke Rehabilitation

Lead Sponsor:

Emory University

Conditions:

Stroke, Cardiovascular

Gait, Hemiplegic

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental q...

Detailed Description

Even after discharge from rehabilitation, residual gait deficits are prevalent in stroke survivors, leading to decreased walking speed and endurance. Because gait dysfunctions limit community mobility...

Eligibility Criteria

Inclusion

  • Stroke participants:
  • age 30-90 years (stroke) or 18-50 years (able-bodied controls)
  • chronic stroke (\>6 months post stroke)
  • ambulatory with or without the use of a cane or walker
  • able to walk for 2 minutes at the self-selected speed without an orthoses
  • resting heart rate 40-100 beats per minute
  • Able-bodied participants:
  • age 18 to 50 years
  • no history of neurologic disease
  • no history of orthopedic disease or injury affecting the lower extremity.

Exclusion

  • Stroke participants:
  • Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements
  • History of lower extremity joint replacement
  • Inability to communicate with investigators
  • Neglect/hemianopia, or unexplained dizziness in last 6 months
  • Neurologic conditions other than stroke
  • Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking or cause pain during walking.
  • Able-bodied controls
  • History of neurologic disease
  • History of orthopedic disease or injury to the lower extremity in the past 6 months
  • Pain or discomfort during walking
  • Cardiovascular or medical condition affecting ability to exercise or walk.

Key Trial Info

Start Date :

March 22 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 3 2018

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03466372

Start Date

March 22 2018

End Date

October 3 2018

Last Update

May 14 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory Univeristy

Atlanta, Georgia, United States, 30322